secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001493152-23-027053
Event type: other_material
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MIRA Pharmaceuticals closes $8.9M IPO; shares begin trading on Nasdaq
---------------------------------------------------------------------

- Priced 1,275,000 shares at $7.00; gross proceeds of $8.9M.
- Nasdaq Capital Market listing under 'MIRA'; trading began Aug 3, 2023.
- Underwriters granted 45-day over-allotment option for 191,250 shares.
- Issued representative's warrants for 63,750 shares at $7.00, exercisable for 5 years.
- Shares issued to MZ as compensation for IPO-related services remain unregistered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/0001493152-23-027053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315223027053/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-027053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer